A detailed history of Superstring Capital Management LP transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Superstring Capital Management LP holds 241,192 shares of CAPR stock, worth $2.22 Million. This represents 2.72% of its overall portfolio holdings.

Number of Shares
241,192
Previous 55,229 336.71%
Holding current value
$2.22 Million
Previous $762 Million 200.32%
% of portfolio
2.72%
Previous 0.66%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$9.49 - $16.11 $1.76 Million - $3 Million
185,963 Added 336.71%
241,192 $2.29 Billion
Q4 2024

Feb 14, 2025

SELL
$12.9 - $21.99 $3.64 Million - $6.2 Million
-282,118 Reduced 83.63%
55,229 $762 Million
Q3 2024

Nov 14, 2024

BUY
$3.56 - $15.21 $1.2 Million - $5.13 Million
337,347 New
337,347 $5.13 Billion

Others Institutions Holding CAPR

About CAPRICOR THERAPEUTICS, INC.


  • Ticker CAPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,346,200
  • Market Cap $224M
  • Description
  • Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...
More about CAPR
Track This Portfolio

Track Superstring Capital Management LP Portfolio

Follow Superstring Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Superstring Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Superstring Capital Management LP with notifications on news.